Mechanisms of anti-cancer action and pharmacology of clofarabine - ScienceDirect
SciELO - Brasil - Marine drugs for cancer: surfacing biotechnological innovations from the oceans Marine drugs for cancer: surfacing biotechnological innovations from the oceans
Acute myeloid leukaemia (AML) and cytarabine pharmacogenomics
Chemical structures of cytarabine and related natural products,... | Download Scientific Diagram
Mathematical Models for the Influence of Cytarabine on White Blood Cell Dynamics in Acute Myeloid Leukemia | bioRxiv
SciELO - Brasil - Marine drugs for cancer: surfacing biotechnological innovations from the oceans Marine drugs for cancer: surfacing biotechnological innovations from the oceans
Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η | Scientific Reports
Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η | Scientific Reports
Cytarabine | C9H13N3O5 - PubChem
Cytarabine nanotherapeutics with increased stability and enhanced lymphoma uptake for tailored highly effective therapy of mantle cell lymphoma - ScienceDirect
Cytarabine conjugates with biologically active molecules and their potential anticancer activity. | Semantic Scholar
The effects of cytarabine combined with ginsenoside compound K synergistically induce DNA damage in acute myeloid leukemia cells - ScienceDirect
Mechanism of action of CPX-351. After intravenous infusion, CPX-351 is... | Download Scientific Diagram
Cytarabine - Wikipedia
Intracellular Pharmacokinetics of Pyrimidine Analogues used in Oncology and the Correlation with Drug Action | SpringerLink
Cancers | Free Full-Text | Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers | HTML
RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia | Pharmacogenomics
Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5′-nucleotidase II expression ratio in primary acute myeloid leukemia cells - ScienceDirect
Phase I and pharmacokinetic study of elacytarabine, a novel 5′-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies | Leukemia
Cytarabine - an overview | ScienceDirect Topics
Combination strategies to promote sensitivity to cytarabine-induced replication stress in acute myeloid leukemia with and without DNMT3A mutations - Experimental Hematology